Precipio, Inc. Common Stock
Follow $PRPO
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PRPO by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredsnapshot unavailable for PRPO. Cause unavailable.
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PRPO moving today?
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PRPO overview
Related filings and maps
Congress activity in PRPO
No receipt-qualified Congressional disclosure is present for PRPO in the cached public ledger.
PRPO contract awards, year to date.
Public federal awards linked to this ticker.
PRPO lobbying filings, year to date.
Registered lobbying filings matched to Precipio, Inc. Common Stock.